Finland re-evaluates health service:
This article was originally published in Clinica
Executive Summary
The Finnish health service is undergoing a major review in order to tackle potential future problems brought on by demographic changes, staff shortages and widening regional disparities in service standards. The evaluation will focus on: funding; staff working conditions and training; the division of labour and co-operation between public and private healthcare; and the assessment and standardisation of healthcare practices. An interim report is already available, based on the recommendations of the evaluation working group, but the final proposals on the future of the health service are expected to be ready by the end of March. They must then be submitted to the national consensus conference for approval.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.